- Home
- ELUT
ELUT
Elutia Inc.
as 12-17-2024 4:00pm EST
Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.
| Founded: | 2015 | Country: | United States |
| Employees: | 54 | City: | SILVER SPRING |
| Market Cap: | 145.2M | IPO Year: | 2020 |
| Target Price: | $10.00 | AVG Volume (30 days): | 42.1K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.07 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.86 - $5.24 | Next Earning Date: | 11-14-2024 |
| Revenue: | $24,782,000 | Revenue Growth: | -2.65% |
| Revenue Growth (this year): | 8% | Revenue Growth (next year): | 39.89% |
Latest Elutia Inc. News
ELUT Breaking Stock News: Dive into ELUT Ticker-Specific Updates for Smart Investing
GlobeNewswire
16 days ago
Elutia Awarded Cardiac Rhythm Management Devices Agreement with Premier, Inc.
Simply Wall St.
a month ago
Elutia Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
GlobeNewswire
a month ago
Elutia Announces Strong Third Quarter Results, Accelerating Toward Full Launch of EluPro® Antibiotic-Eluting BioEnvelope in 2025
GlobeNewswire
a month ago
Elutia to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
GuruFocus.com
a month ago
What To Expect From Elutia Inc (ELUT) Q3 2024 Earnings
GlobeNewswire
2 months ago
Elutia to Report Third Quarter 2024 Financial Results on Thursday, November 14, 2024
GlobeNewswire
2 months ago
Elutia to Present at the LD Micro Main Event XVII Conference on Wednesday, October 30
ACCESSWIRE
2 months ago
SWK Holdings Provides Portfolio Update
Compare ELUT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ELUT Elutia Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.